MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 169 filers reported holding MEDICINES CO in Q4 2014. The put-call ratio across all filers is 1.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,258,000 | -6.0% | 37,079 | +4.5% | 0.00% | 0.0% |
| Q3 2016 | $1,339,000 | +22.8% | 35,478 | +9.5% | 0.00% | 0.0% |
| Q2 2016 | $1,090,000 | +9.8% | 32,401 | +3.6% | 0.00% | 0.0% |
| Q1 2016 | $993,000 | -6.8% | 31,270 | +9.5% | 0.00% | 0.0% |
| Q4 2015 | $1,066,000 | -32.6% | 28,557 | -31.5% | 0.00% | -50.0% |
| Q3 2015 | $1,582,000 | +26.7% | 41,686 | -4.5% | 0.00% | +100.0% |
| Q2 2015 | $1,249,000 | +7.4% | 43,654 | +5.2% | 0.00% | 0.0% |
| Q1 2015 | $1,163,000 | +18.7% | 41,498 | +17.2% | 0.00% | 0.0% |
| Q4 2014 | $980,000 | +17.9% | 35,412 | -4.9% | 0.00% | 0.0% |
| Q3 2014 | $831,000 | -24.6% | 37,219 | -1.8% | 0.00% | 0.0% |
| Q2 2014 | $1,102,000 | -85.1% | 37,917 | -85.5% | 0.00% | -85.7% |
| Q1 2014 | $7,420,000 | -61.3% | 261,082 | -47.4% | 0.01% | -61.1% |
| Q4 2013 | $19,151,000 | -3.3% | 495,895 | -16.1% | 0.02% | -10.0% |
| Q3 2013 | $19,814,000 | -19.3% | 591,116 | -25.9% | 0.02% | -23.1% |
| Q2 2013 | $24,552,000 | – | 798,165 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,778,742 | $138,680,000 | 22.51% |
| Sarissa Capital Management LP | 1,922,000 | $70,537,000 | 14.14% |
| Antipodean Advisors LLC | 165,500 | $6,074,000 | 7.66% |
| Boxer Capital, LLC | 1,250,000 | $45,875,000 | 5.19% |
| BRIDGER MANAGEMENT, LLC | 2,604,965 | $95,602,000 | 5.18% |
| Slate Path Capital LP | 1,730,000 | $63,491,000 | 4.80% |
| HighVista Strategies LLC | 268,240 | $9,844,000 | 4.44% |
| Camber Capital Management LP | 2,000,000 | $73,400,000 | 2.82% |
| Lion Point Capital, LP | 727,205 | $26,688,000 | 2.40% |
| THREE BAYS CAPITAL LP | 1,360,560 | $49,933,000 | 1.94% |